Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Author： Lordick Florian Lorenzen Sylvie Yamada Yasuhide Ilson David

ISSN： 1436-3291

Source： Gastric Cancer, Vol.17, Iss.2, 2014-04, pp. : 213-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Second-line chemotherapy for advanced gastric cancer in Korea

By Baek Sun Kim Si-Young Jeong Jae-heon Cho Kyung Yoon Hwi-Joong

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 345-354

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy in the Treatment of Metastatic Gastric Cancer: Is There a Global Standard?

By Kang Hyunseok

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 96-106

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1309-1314

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1451-1457

Spandidos Publications

Access to resources Recommend Favorite

Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer

By Shim Hyun

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 249-256

Springer Publishing Company

Access to resources Recommend Favorite